EuropaBio Most innovative European Biotech SME Award 2014

 

About the award

EuropaBio’s Most Innovative European Biotech SME Award aims to showcase European Biotech SMEs that have developed an innovative solution to technical, social and environmental problems.  The award is committed to strengthening the biotechnology and innovation arena in Europe while promoting and empowering SMEs to generate novel solutions to unmet needs.

Entering its 5th year, the award has grown rapidly reaching a wide audience across Member States and is expected to once again attract a large number of applications from right across the EU. The European Biotech SME Award is geared towards small and medium-sized companies in all areas of biotechnology: health, agriculture, and industry.  It seeks to give recognition for companies that are developing innovative products and approaches to achieve that aim.

The SME Award takes place during the European Biotech Week- a showcase of the benefits of biotechnology for society, with 100's of events taking place right accross the EU

Criteria for entry

Applicants must qualify as an SME under the standard EU SME definition outlined in the European Commission 'SME User Guide'

The applicants will be judged on the following criteria: response to social/environmental needs, business strategy, raising capital and innovation/ ‘wow’ factor.

Selection process and prize giving

During the selection process, an expert judging panel will analyse all applications and choose five finalists. These top five will be invited to present their innovative findings to the judging panel and an audience of high-level EU decision makers and venture capitalists in Brussels.  All candidates will receive two year’s free membership of EuropaBio, and the overall winner will receive a prize of €10,000.

Previous Winners

 

Winner

Runners up

2014

Erytech Pharma (France)

Bio-on (Italy)

Biosyntia (Denmark)

Autifony Therapeutics (UK)

BBB Therapeutics (the Netherlands)

 

 

2013

PsiOxus Therapeutics(UK)

EryDel SpA(Italy); 

ETherapeutics(UK);    

Gensight(France);       

Nanobiotix(France);

2012

 ProtAffin AG(Austria)

 Global Bioenergies(France)

Green Biologics Ltd (UK)

Promethera BioSciences(Belgium)

to-BBB(The Netherlands)

2011

 Prosensa Therapeutics(The Netherlands)

Aicuris GmbH & CO (Germany)

Biocentras (Lithuania)

Cardio3 BioSciences (Belgium)

to-BBB(The Netherlands)

2010

Addex Pharmaceuticals (Sweden)

AMsilk (Germany)

TiGenix (Belgium)

KeyGene (The Netherlands)

Prosena (The Netherlands)

Find out more

Hear first-hand what Europe's leading minds are doing to build a better future for our citizens and what challenges they face during the EuropaBio's 5th Annual Most Innovative EU Biotech SME Award ceremony on 08th of October, at Stanhope Hotel in Brussels

EuropaBio opening the Euronext markets in Brussels, on 08 October, to mark the 5th Annual Most Innovative EU Biotech SME Award and ENTENTE-Life Sciences Investor Forum on 09 October.

Download the 2014 application pack

Download the 2014  programme and presentations

Read all about the launch of our 2014 award in our press release

Read more about the winner of the 2013 Most Innovative European Biotech SME Award in the press release here.

Read more about the winners of the 2014 Most Innovative European Biotech SME Award in the press release here.

Take a look at last years event video here.

Visit the European Biotech Week website and take a look inside European Biotech Week Magazine to learn more about the events that took place all across the EU.

For more information about the 2014 SME award, or the European Biotech Week, please contact EuropaBio SME and Communications Manager, Rosalind Travers: r.travers{@}europabio.org